{"id":558765,"date":"2026-07-15T12:30:00","date_gmt":"2026-07-15T10:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=558765"},"modified":"2026-07-15T13:19:13","modified_gmt":"2026-07-15T11:19:13","slug":"sglt-2-i-e-glp-1-ra-melhoria-significativa-nos-parametros-renais","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/sglt-2-i-e-glp-1-ra-melhoria-significativa-nos-parametros-renais\/","title":{"rendered":"SGLT-2-i e GLP-1-RA: melhoria significativa nos par\u00e2metros renais"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Cerca de 30 a 40 % dos doentes com diabetes tipo 2 desenvolvem, ao longo da doen\u00e7a, uma doen\u00e7a renal cr\u00f3nica (DRC). Em estudos \u00abmarcantes\u00bb, como o CREDENCE, o DAPA-CKD, EMPA-KIDNEY e alguns outros,<em> os inibidores da SGLT-2 (transportador de s\u00f3dio-glicose 2)<\/em>obtiveram benef\u00edcios comprovados nos par\u00e2metros renais e, com o estudo FLOW, foi agora tamb\u00e9m poss\u00edvel demonstrar efeitos nefroprotetores significativos com o<em> GLP-1 (pept\u00eddeo semelhante ao glucagon 1)-RA<\/em>em doentes com diabetes tipo 2.   <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fsglt-2-i-e-glp-1-ra-melhoria-significativa-nos-parametros-renais%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Cerca de 30 a 40 % dos doentes com diabetes tipo 2 desenvolvem, ao longo da doen\u00e7a, uma doen\u00e7a renal cr\u00f3nica (DRC). Em estudos \u00abmarcantes\u00bb, como o CREDENCE, o DAPA-CKD,&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fsglt-2-i-e-glp-1-ra-melhoria-significativa-nos-parametros-renais%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":558766,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Doen\u00e7a renal cr\u00f3nica em doentes com diabetes tipo 2: tratamento otimizado baseado em evid\u00eancias","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11551,11397,11521,11524,11305,11426],"tags":[24260,13003,94785,66530,23326,12023,13010,94793,44079,94791,20819,65626,94787,94789,18638],"powerkit_post_featured":[],"class_list":["post-558765","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-pt","category-endocrinologia-e-diabetologia-2","category-estudos","category-formacao-continua","category-medicina-interna-geral","category-nefrologia-pt-pt","tag-canagliflozin-pt-pt","tag-ckd-pt-pt","tag-credence","tag-dapa-ckd-pt-pt","tag-dapagliflozin-pt-pt","tag-diabetes-tipo-2-pt-pt","tag-doenca-renal-cronica","tag-efeitos-nefroprotetores","tag-empagliflozin-pt-pt","tag-estudo-flow","tag-forxiga-pt-pt","tag-glp-1-ra-pt-pt","tag-jardiance","tag-ozempic","tag-sglt-2-i-pt-pt","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-27 18:52:35","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":558772,"slug":"inhibidores-de-sglt-2-y-agonistas-selectivos-del-glp-1-mejora-significativa-de-los-criterios-de-valoracion-renales","post_title":"Inhibidores de SGLT-2 y agonistas selectivos del GLP-1: mejora significativa de los criterios de valoraci\u00f3n renales","href":"https:\/\/medizinonline.com\/es\/inhibidores-de-sglt-2-y-agonistas-selectivos-del-glp-1-mejora-significativa-de-los-criterios-de-valoracion-renales\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/558765","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=558765"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/558765\/revisions"}],"predecessor-version":[{"id":561393,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/558765\/revisions\/561393"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/558766"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=558765"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=558765"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=558765"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=558765"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}